Concept information
Preferred term
Sitagliptin Phosphate
Type
-
mesh:Descriptor
Definition
- A pyrazine-derived DIPEPTIDYL-PEPTIDASE IV INHIBITOR and HYPOGLYCEMIC AGENT that increases the levels of the INCRETIN hormones GLUCAGON-LIKE PEPTIDE-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). It is used in the treatment of TYPE 2 DIABETES.
Narrower concepts
Entry terms
- 486460-32-6 (sitagliptin)
- 494P4635I6
- 654671-77-9 (sitagliptin phosphate)
- QFP0P1DV7Z
- Sitagliptin Monophosphate Monohydrate
- Sitagliptin Phosphate Monohydrate
- TS63EW8X6F
Allowable Qualifier(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
Pharmacological Action(s)
In other languages
-
French
-
486460-32-6 (sitagliptin)
-
494P4635I6
-
654671-77-9 (sitagliptin phosphate)
-
Phosphate de sitagliptine monohydraté
-
QFP0P1DV7Z
-
TS63EW8X6F
URI
http://data.loterre.fr/ark:/67375/JVR-MGHS2S7F-H
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}